Lumeda Inc. is a medical technology company advancing photodynamic therapy (PDT) as an adjuvant treatment for patients with non-small cell lung cancer (NSCLC) and other thoracic malignancies. Lumeda’s breakthrough light dosimetry product called DigiLum is designed to activate a photosensitizer drug and deliver PDT to reduce the recurrence of cancer and enhance antitumor immunity. DigiLum applies advanced photonics and proprietary Artificial Intelligence (AI) software to enable thoracic surgeons to control dosimetry, reduce treatment time and capture data for future treatment planning.

Biotechnology

Education

Lumeda

Trevor MacDougall

Paul E. Sanders

Marc LaPierre

Lumeda's CEO and Executive Team includes Alexander Zinke.

CEO and Executive Team

Board of Directors

Leadership Team

Founding Team

CEO and Executive Team

About

Other teams at Lumeda

Board of Directors

Leadership Team

Founding Team